Dr. Isabel Cunningham: Treatment of Myeloproliferative Neoplasms Comes of Age

Interview by L Scott Zoeller. 2012 Jan 10, Isabel Cunningham, MD

To mark 2011, we have asked our distinguished OncologySTAT Advisory Board Members to choose their top story of the year. Dr. Isabel Cunningham discusses her choice for the year’s most important development in myeloproliferative diseases. OncologySTAT: In your view, which development in oncology research that occurred in 2011 could have the most significant impact in the area of myeloproliferative neoplasms (MPNs)?Dr. Cunningham: The 2011 explosion of studies (>2000 articles and >3000 ASH abstracts)...

NOT A MEMBER?

Registration is FREE

  • Up-to-date oncology news
  • Journal article summaries
  • Commentaries and interviews
  • Drug and interactions database
  • Chemotherapy regimens
  • Daily e-newsletters

 

Meet Our Experts

Meet our Advisory and Editorial Boards comprised of physician editors and world-renowned experts.

Editors' Choice

Everolimus Plus Tamoxifen Improves Survival in Metastatic Breast Cancer

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
  • Forgot your password?
    Not a member? Free registration